本页面由Tiger Trade Technology Pte. Ltd.提供服务

Edgewise Therapeutics, Inc.

32.70
+0.01000.03%
盘后32.700.00000.00%17:43 EDT
成交量:68.14万
成交额:2,224.00万
市值:35.08亿
市盈率:-19.66
高:33.55
开:32.92
低:32.32
收:32.69
52周最高:39.96
52周最低:12.15
股本:1.07亿
流通股本:6,084.98万
量比:0.77
换手率:1.12%
股息:- -
股息率:- -
每股收益(TTM):-1.6631
每股收益(LYR):-1.6302
净资产收益率:-38.14%
总资产收益率:-25.64%
市净率:7.11
市盈率(LYR):-20.06

数据加载中...

2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/20

重要事件披露

Form 8-K - Current report
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/10

重要事件披露

Form 8-K - Current report
2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]